U.K. ratchets up antidepressant warnings

Following the FDA's lead, U.K. regulators have upgraded warnings on all antidepressants to include an increased risk of suicidal thoughts and behavior among young adults taking the meds.

The Medicines and Healthcare Regulatory Agency checked out the FDA's review of safety data, and then concluded that the risk of suicidality was higher in young people. And, the agency said, the risk was the same "across the different antidepressant classes," so labels will be revised not only on SSRIs like Paxil and Prozac, but on other antidepressants such as Effexor and Wellbutrin.

- check out the MHRA's release
- read the item at Pharmalot

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.